CD8A and lung cancer: in a preclinical model of lung cancer was the efficacy of a new radiotherapy regimen (22 Gy followed by 0.5 Gy × 4 days) in increasing the infiltration of Granzyme B+CD8+ T cells within TME, while simultaneously reducing immune suppression caused by Tregs and M2 macrophages when compared to standard SBRT.